Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 15

    1.

    Inactivation of 9q22.3 tumor suppressor genes predict outcome for patients with head and neck squamous cell carcinoma.

    Ghosh A, Maiti GP, Bandopadhyay MN, Chakraborty J, Biswas J, Roychoudhury S, Panda CK.

    Anticancer Res. 2013 Mar;33(3):1215-20.

    PMID:
    23482805
    [PubMed - indexed for MEDLINE]
    2.

    Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delay.

    Muller EA, Aradhya S, Atkin JF, Carmany EP, Elliott AM, Chudley AE, Clark RD, Everman DB, Garner S, Hall BD, Herman GE, Kivuva E, Ramanathan S, Stevenson DA, Stockton DW, Hudgins L.

    Am J Med Genet A. 2012 Feb;158A(2):391-9. doi: 10.1002/ajmg.a.34216. Epub 2011 Dec 21.

    PMID:
    22190277
    [PubMed - indexed for MEDLINE]
    3.

    Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.

    Ghosh A, Ghosh S, Maiti GP, Mukherjee S, Mukherjee N, Chakraborty J, Roy A, Roychoudhury S, Panda CK.

    Ann Surg Oncol. 2012 Jul;19 Suppl 3:S528-38. doi: 10.1245/s10434-011-1991-x. Epub 2011 Aug 23.

    PMID:
    21861228
    [PubMed - indexed for MEDLINE]
    4.

    Overgrowth of prenatal onset associated with submicroscopic 9q22.3 deletion.

    Kosaki R, Fujita H, Ueoka K, Torii C, Kosaki K.

    Am J Med Genet A. 2011 Apr;155A(4):903-5. doi: 10.1002/ajmg.a.33835. Epub 2011 Mar 15. No abstract available.

    PMID:
    21412971
    [PubMed - indexed for MEDLINE]
    5.

    Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients.

    Kazakov DV, Vanecek T, Zelger B, Carlson JA, Spagnolo DV, Schaller J, Nemcova J, Kacerovska D, Vazmitel M, Sangüeza M, Emberger M, Belousova I, Fernandez-Figueras MT, Kempf W, Meyer DR, Rütten A, Baltaci M, Michal M.

    Am J Dermatopathol. 2011 May;33(3):251-65. doi: 10.1097/DAD.0b013e3181f7d373. Erratum in: Am J Dermatopathol. 2011 Dec;33(8):874. Fernandez-Figueraz, Maria Tereza [corrected to Fernandez-Figueras, Maria Tereza].

    PMID:
    21389835
    [PubMed - indexed for MEDLINE]
    6.

    Microdeletion of 22q11.1 is associated with two cases of familial nonsyndromic basal cell carcinoma.

    Naderi A.

    Cancer Genet Cytogenet. 2010 Oct 15;202(2):133-5. doi: 10.1016/j.cancergencyto.2010.07.123.

    PMID:
    20875876
    [PubMed - indexed for MEDLINE]
    7.

    Clinical features of microdeletion 9q22.3 (pat).

    Shimojima K, Adachi M, Tanaka M, Tanaka Y, Kurosawa K, Yamamoto T.

    Clin Genet. 2009 Apr;75(4):384-93. doi: 10.1111/j.1399-0004.2008.01141.x.

    PMID:
    19320658
    [PubMed - indexed for MEDLINE]
    8.

    Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature.

    Yamamoto K, Yoshihashi H, Furuya N, Adachi M, Ito S, Tanaka Y, Masuno M, Chiyo H, Kurosawa K.

    Congenit Anom (Kyoto). 2009 Mar;49(1):8-14. doi: 10.1111/j.1741-4520.2008.00212.x.

    PMID:
    19243411
    [PubMed - indexed for MEDLINE]
    9.

    Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.

    Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK.

    Mol Cancer. 2008 Nov 6;7:84. doi: 10.1186/1476-4598-7-84.

    PMID:
    18990233
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Novel microdeletion syndromes detected by chromosome microarrays.

    Slavotinek AM.

    Hum Genet. 2008 Aug;124(1):1-17. doi: 10.1007/s00439-008-0513-9. Epub 2008 May 30. Review.

    PMID:
    18512078
    [PubMed - indexed for MEDLINE]
    11.

    Loss of the PTCH1 gene locus in cardiac fibroma.

    Scanlan D, Radio SJ, Nelson M, Zhou M, Streblow R, Prasad V, Reyes C, Perry D, Fletcher S, Bridge JA.

    Cardiovasc Pathol. 2008 Mar-Apr;17(2):93-7. doi: 10.1016/j.carpath.2007.08.001. Epub 2007 Oct 24.

    PMID:
    18329553
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder.

    Abdel Wahab AH, Abo-Zeid HI, El-Husseini MI, Ismail M, El-Khor AM.

    J Egypt Natl Canc Inst. 2005 Dec;17(4):260-9.

    PMID:
    17102820
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3-->q31.3) associated with Gorlin syndrome.

    Chen CP, Lin SP, Wang TH, Chen YJ, Chen M, Wang W.

    Prenat Diagn. 2006 Aug;26(8):725-9.

    PMID:
    16927391
    [PubMed - indexed for MEDLINE]
    14.

    Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome.

    Redon R, Baujat G, Sanlaville D, Le Merrer M, Vekemans M, Munnich A, Carter NP, Cormier-Daire V, Colleaux L.

    Eur J Hum Genet. 2006 Jun;14(6):759-67.

    PMID:
    16570072
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes.

    Sironi E, Cerri A, Tomasini D, Sirchia SM, Porta G, Rossella F, Grati FR, Simoni G.

    J Cutan Pathol. 2004 Apr;31(4):318-22.

    PMID:
    15005689
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk